Research program for patients with “Acute” Hepatitis A

HAV

Access Clinical/Access Biologicals is seeking those who have been diagnosed as having “acute” hepatitis a.  Plasma donors are the key ingredient in the manufacturing of diagnostic controls for test kits, and without plasma donors who have this virus these kits run the risk of going on back order. If you, or someone you know currently has hepatitis a virus you are needed to help research.

Participants who donate in the program are compensated $500 each time they donate and you can safely donate 2x in a 7 day period.  If we have to travel you all your travel expenses are paid by us and you will earn $1000 per week for helping.

To learn more and to inquire, visit http://www.accessclinical.com to learn more.

What is Hepatitis A?

Hepatitis A is a highly contagious liver infection caused by the Hepatitis A virus.  it can range in severity from a mild illness lasting a few weeks to a severe illness lasting several months.

What are the symptoms of Hepatitis A?

Not everyone will have symptoms.  If symptoms develop, they usually appear 2-6 weeks after infection and include:

Fever, Vomiting, Grey colored stools, fatigue, abdominal pain, joint pain, loss of appetite, nausea, dark urine and jaundice. (yellowing of the skin & eyes)

Symptoms are more likely to occur in adults than in children.  The symptoms usually last less than 2 months, although some people can be ill for as long as 6 months.

How is Hepatitis A diagnosed?

A doctor can determine if a person has Hepatitis A by discussing symptoms and taking a blood sample that is tested for the virus.  To treat Hepatitis A, doctors usually recommend rest, good nutrition, fluids and medical monitoring of your liver enzymes, and some people will need to be hospitalized.  It can take a few months before some people start to feel better.

How serious is it?

Most people who get hepatitis A feel sick for several month, but they usually recover completely and do not have lasting liver damage.  Sometimes it can cause liver failure and death, although this is rate and occurs more commonly in people who are older than 50 and in people with other liver diseases.